Table 4.
Effects of BS on diabetes mellitus, nutrition and lipids
| Variables | 6 months pre-BS | 3 months pre-BS | Baseline | Month 3 | Month 6 | Month 12 | Month 24 |
|---|---|---|---|---|---|---|---|
| Glucose (mg/dL) | 143.1 ± 58.1 | 158.2 ± 65 | 164 ± 68.5 | 98 ± 21.1* | 91.6 ± 18.4* | 88.1 ± 19.1* | 86.7 ± 14* |
| Glycated haemoglobin (%) | 7.2 ± 1.7 | 7.6 ± 2.1 | 7.3 ± 1.8 | 5.7 ± 0.8* | 5.4 ± 0.7* | 5.4 ± 0.8* | 5.4 ± 0.7* |
| Diabetes, % | 66.7 | 66.7 | 66.7 | 0* | 0* | 0* | 8.3* |
| Insulin, % | 62.5 | 62.5 | 62.5 | 0* | 0* | 0* | 0* |
| Oral anti-diabetics, % | 62.5 | 62.5 | 62.5 | 0* | 0* | 0* | 8.3* |
| Pre-albumin (mg/dL) | 28.2 ± 5.3 | 26.4 ± 4.2 | 26.8 ± 4.7 | 20.9 ± 6* | 22.3 ± 5.3* | 22.9 ± 4.6* | 24.1 ± 4.3 |
| Albumin (mg/dL) | 4.2 ± 0.3 | 4.2 ± 0.2 | 4.2 ± 0.5 | 4.2 ± 0.4 | 4.2 ± 0.4 | 4.2 ± 0.4 | 4.1 ± 0.4 |
| Homocysteine (μmol/L) | 13.4 ± 6.7 | 13.5 ± 6.3 | 15 ± 8.3 | 16.8 ± 6.4 | 17.5 ± 6.8 | 16.7 ± 6.4 | 15.3 ± 5.9 |
| Vitamin D (ng/mL) | 10.8 ± 4.8 | 13.3 ± 4.6 | 14.1 ± 6.1 | 13.7 ± 4.4 | 16.9 ± 8.6 | 19.4 ± 9.2 | 19.2 ± 10.5 |
| Cholesterol (mg/dL) | 185.7 ± 34.6 | 181.6 ± 41.6 | 198.1 ± 49.3 | 167.5 ± 33.4* | 167.6 ± 34.6* | 164.8 ± 42.6* | 163.3 ± 29.7* |
| HDL cholesterol (mg/dL) | 36.6 ± 7.3 | 35.5 ± 6.7 | 35.9 ± 8.9 | 41.1 ± 10 | 42.3 ± 9.4 | 48.5 ± 12.2* | 55.6 ± 17.6* |
| LDL cholesterol (mg/dL) | 104.2 ± 41.3 | 101.7 ± 38.3 | 110.6 ± 43.1 | 93.6 ± 33.7 | 95.8 ± 35.9 | 93.8 ± 40 | 88.4 ± 32.9 |
| Triglycerides (mg/dL) | 301.2 ± 138.6 | 293.6 ± 169.2 | 302.2 ± 109.9 | 164.9 ± 48.7* | 128.4 ± 45.8* | 121.2 ± 47.8* | 112.2 ± 43.7* |
| Hyperlipidaemia, % | 83.3 | 83.3 | 83.3 | 16.7 | 16.7 | 16.7 | 16.7 |
| Statins, % | 58.3 | 58.3 | 58.3 | 16.7 | 16.7 | 16.7 | 16.7 |
| Fibrates, % | 25 | 25 | 25 | 0 | 0 | 0 | 0 |
*
Values are presented as mean ± SD unless stated otherwise.P < 0.05 versus baseline.